July 29, 2020
Pfizer Japan said on July 28 that it has launched new tablet formulations of its breast cancer treatment Ibrance (palbociclib) in Japan. Ibrance 25 mg/125 mg Tablets are smaller in size and thus easier for patients to take than the...read more